Chain Drug Review

View more issues:

Articles in April 20, 2009 issue of Chain Drug Review

• Poor retail sales, job losses jolt economy
• Chain drug suppliers post big profit gain
• Judge blocks Medicaid cuts in Washington state
• Wal-Mart, Fehlig go separate ways
• Brunner kept things interesting
  by David Pinto
• Rite Aid forges plan to improve results
• Surescripts taps Totonis for CEO post
• Meyer ends career at Walgreens
• Walgreens launches Take Care Recovery Plan
• Clinics will explain offer to patients
• Wal-Mart adds to its arsenal
• CVS Caremark works to increase patient engagement
• Grove Medical introduces Sensis condoms line
• Advanced Beauty names two VPs
• Better planning gives Church & Dwight competitive edge
• Salvatori-Scott intent on extending its reach
• Vitaball's new gum contains nutrients
• AHP offers solutions for pharmaceutical industry
• Onetime items lead to more red ink at Rite Aid
• Outlook for fiscal '10 cautious
• Earnings fall 6.7% at Walgreens in second quarter
• Community pharmacy has come a long way
  by Jeffrey Woldt
• What lies behind the new face of SKU rationalization
  by Tim Hendricks
• Retailer, manufacturer communication is vital
• Drug stores meet many needs
  by Tom Palmer
• Chain drug retailers muddle through up-and-down year
  by David Pinto
• Recession's end on horizon?
• Jury still out on stimulus plan
• Financial results reveal top chain drug performers
• Retailers battle to win shoppers
• Top 50 drug chains by dollar volume
• Econ 09 delivers actionable insights
• NACDS benefiting from Giancamilli's broad vision
• 'We know we need to help elect friends of retail pharmacy'
• Anderson positions NACDS to build on victories
• As recession impacts Rx, health care reform looms
• Coalition agrees on principles
• The business community joins calls for change
• Obama quick to unveil plan to fix health care
• Administration puts team members in place
• Industry has a lot riding on two legal cases
• Pharmacy groups weigh in on reform
• Rx discounts keep proliferating
• A new model keeps evolving
• Rate of expansion is likely to slow
• Workplace becomes new practice setting
• Discount stores make more inroads in retail pharmacy
• Wal-Mart enlarges 'competitive moat'
• Sears bets on five-part plan to revive fortunes
• As retail scene changes, appeal of combos endures
• Pharmacy essential to the mix
• Rx customers give format high marks
• Extreme-value retailers raise profile during downturn
• Dollar Tree is 'more relevant than ever'
• Family Dollar sharpens focus
• Consumers adjust their expectations
• Rx holds steady in Canada
• Spending habits likely to change
• Demographics alter the equation
• Value is the new watchword
• Industry committed to going green
• Retail tech has positive impact on bottom line
• Making cross-channel selling work
• Distribution facilitated by robotics
• Systems can "expand customer touch points'
• Study tracks retailers' technology priorities
• Community pharmacy embraces the online age
• There's still a lot of work to be done on HIT
• Acceptance of kiosks on the rise
• Telepharmacy's reach continues to expand
• Drug makers under the gun
• Biotechnology R&D stays on fast track
• Development of cancer treatments gets high priority
• Tough times highlight positive impact of generics
• Walgreens ready to be 'part of health care solution'
• New CEO emerges as a driving force for change
• Alaska: the final frontier
• Workplace Rx division key part of strategy
• Management ranks get new blood
• Walgreens

• 1
• 2
• 3
• 4